Rotigotine 4Mg/24Hrs Patch

DRUG2 trials

Sponsors

I.R.C.C.S. Fondazione Santa Lucia

Conditions

Alzheimer DiseaseAphasiaAphasia, Primary ProgressiveBrain DiseasesCentral Nervous System DiseasesCommunication DisordersDementiaFrontotemporal Dementia

Phase 2

Dopaminergic Therapy for Frontotemporal Dementia Patients

CompletedNCT04937452

I.R.C.C.S. Fondazione Santa LuciaAphasia, Aphasia, Primary Progressive, Brain Diseases +17

Start: 2021-06-03End: 2024-04-01Updated: 2024-10-22

Phase 3

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

RecruitingNCT06702124

I.R.C.C.S. Fondazione Santa LuciaAlzheimer Disease

Start: 2023-12-01End: 2026-04-30Target: 348Updated: 2025-01-22

Related Papers

Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial.

2025-08-051 citations